Alternative
Melatonin
search
Melatonin
See Also
Insomnia
Herbal Medicine
Indications
Sleep
onset
Insomnia
Non-24 hour sleep wake disorder (blind patients)
Delayed Sleep Phase
Syndrome (adolescents)
Jet Lag
Night Shift Worker
s with
Insomnia
(less effective)
Physiology
Pineal gland synthesizes Melatonin
Overall Pathway:
Tryptophan
to
Serotonin
to Melatonin
May also affect adrenal and gonadal function
Endogenous Melatonin physiology
Secreted at night
Normally highest levels during sleep
Increases rapidly late evening
Peaks after midnight
Decreases in Morning
Potential Effects on
Sleep
Improved
Sleep Efficiency
(
Sleep
Time/Time in bed)
Decreased Nocturnal Awakenings
Improved
Sleep
quality
Does not Decrease
Sleep Latency
Does not Increase total sleep time
As compared with
Benzodiazepine
s
Not addictive
Does not suppress
REM Sleep
Does not increase morning
Sleepiness
Future Potential uses
Chemotherapeutic
Pathophysiology
Elderly with
Insomnia
Low levels of Melatonin
Blind with irregular sleep cycles
Free running Melatonin
Exogenous Melatonin shown to normalize sleep rhythms
Melatonin 5mg at bedtime for 3 weeks
References
Sack (1991) J Biol Rhythms 6:249 [PubMed]
Sources
Marketed as a dietary supplement
Not regulated by FDA
No information on production, purity, manufacturer
Risk of impurities
Example: L-
Tryptophan
related deaths
Consumers should purchase USP Verified products
Dosing
Gene
ral
Effective doses are lower than package insert
May be effective for promoting sleep onset
Not effective for maintaining sleep (extending sleep duration)
Does not require tapering
Dosing by age
Child (over age 6 months): Start at 1 mg (maximum effective dose 3 mg)
Teens: Start at 3 mg (maximum dose 5 mg)
Adult: Start at 3 mg (maximum effective dose 6 mg, absolute maximum 10 mg)
Dosing
Specific Indications in Adults
Night Shift Worker
s
Start with 3 mg prior to daytime sleep (may increase to 5 mg)
Sleep
onset
Insomnia
Start with 3 mg at 30 to 60 minutes before bedtime (may increase to 5 mg)
Jet Lag
Melatonin 5 mg orally at bedtime on arrival at destination and for 2-6 nights after arrival
Efficacy
Jet Lag
Recent Cochrane review suggests effective at travel
Indications
Travel across 5 or more time zones
May also be useful if 2 or more time zones crossed
Most effective when traveling eastward
Protocol
Take 5 mg PO at bedtime on arrival at destination
Continue for 2-5 days after arrival
References
Smucny (2002) Am Fam Physician 66(11):2087-8 [PubMed]
Other small trials show benefit at travel time
Petrie (1989) Br Med J 298:705
Before travel: 5 mg PO at bedtime for 3 days
After travel: 5 mg PO at bedtime for 3 days
Petrie (1993) Biol Psychiatry 33:526
After travel: 5 mg PO at bedtime for 5 days
Claustrat (1992) Biol Psychiatry 32:705
Before travel: 8 mg PO at bedtime for 1 day
After travel: 8 mg PO at bedtime for 3 days
Trials showing lack of Melatonin benefit in
Jet Lag
Hao (2000) J Clin Endocrinol Metab 85(10):3618-22
Efficacy
Insomnia
Some small trials suggest benefit
Garfinkel (1995) Lancet 346:541
Melatonin 2 mg PO 2 hours before bedtime
Dollins (1994) Proc Natl Acad Sci 91:1824
Melatonin 0.3 to 1 mg PO 1-2 hours before bedtime
Zhadanova (1995) Clin Pharmacol Ther 57:552
Melatonin 0.3 to 1 mg PO 1-2 hours before bedtime
Safety
Not recommended in pregnancy and
Lactation
due to insufficient safety data
May effect growth in children on Melatonin longterm (hormonal suppression)
Adverse Effects
Standard dosing
See Safety as above
Drowsiness
Onset 30 minutes after administered
Duration: 1 hour
Headache
Gastrointestinal upset
Major Depression
Nausea
Seizure
risk
May increase risk of
Seizure
s in those with
Epilepsy
or drugs that lower
Seizure
threshold (e.g.
Bupropion
)
Adverse Effects
Higher doses (e.g. 10 mg, often mixed with other supplements)
Hangover
Sensation
Lethargy
Disorientation
Amnesia
Myths
False Claims or myths without scientific support
Anti-Aging effect
Heart and
Immune System
Strengthening
Improved Sexual Libido and Vitality
Seasonal Affective Disorder
treatment
Drug Interactions
May increase levels of
CYP1A2
metabolized drugs
May increase levels of
CYP2C19
metabolized drugs
References
(2023) Presc Lett 30(9): 54
(2022) Presc Lett 29(3): 17
Cupp (1997) Am Fam Physician 56(5):1421-1425 [PubMed]
Type your search phrase here